141 related articles for article (PubMed ID: 16710903)
1. Why media relations matter.
Kureczka JE
Nat Biotechnol; 2006 Apr; 24(4):387-9. PubMed ID: 16710903
[TBL] [Abstract][Full Text] [Related]
2. Assets for mastering media relations.
Steinerman P
Nat Biotechnol; 2003 Jul; 21 Suppl():BE59-61. PubMed ID: 12874984
[No Abstract] [Full Text] [Related]
3. Marriage guidance for collaborators.
Hogan J
Med Device Technol; 2005 Mar; 16(2):25-6. PubMed ID: 15828497
[TBL] [Abstract][Full Text] [Related]
4. Earlier stage biotechs attract partners.
Ratner M
Nat Biotechnol; 2005 May; 23(5):509. PubMed ID: 15877052
[No Abstract] [Full Text] [Related]
5. Benefits of biotech clusters questioned.
Sheridan C
Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
[No Abstract] [Full Text] [Related]
6. Dealing with the media.
Gardner C; Pickering P
Nat Biotechnol; 2002 Jul; 20 Suppl():BE67-9. PubMed ID: 12089594
[No Abstract] [Full Text] [Related]
7. The benefits of design partnership.
Hogan J
Med Device Technol; 2005 May; 16(4):34-5. PubMed ID: 15941198
[TBL] [Abstract][Full Text] [Related]
8. University spin-offs: opportunity or challenge?
Peng X
Nat Mater; 2006 Dec; 5(12):923-5. PubMed ID: 17139301
[No Abstract] [Full Text] [Related]
9. France to focus on a few biotech clusters.
Balcon E
Nat Biotechnol; 2004 Sep; 22(9):1063-4. PubMed ID: 15340457
[No Abstract] [Full Text] [Related]
10. Exiting this year and into the next.
Nat Biotechnol; 2005 Dec; 23(12):1451. PubMed ID: 16333272
[No Abstract] [Full Text] [Related]
11. Swedish roadtrip.
Herrera S
Nat Biotechnol; 2006 Jan; 24(1):15. PubMed ID: 16475247
[No Abstract] [Full Text] [Related]
12. Biotech parks proliferate, despite concerns over sustainability.
Jia H; Jayaraman KS; Orellana C
Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
[No Abstract] [Full Text] [Related]
13. Reverse mergers attract top-tier biotechs in sluggish IPO market.
Lawrence S
Nat Biotechnol; 2006 Jun; 24(6):598-9. PubMed ID: 16763574
[No Abstract] [Full Text] [Related]
14. The role of competitive intelligence in biotech startups.
Carlucci S; Page A; Finegold D
Nat Biotechnol; 2005 May; 23(5):525-7. PubMed ID: 15942983
[No Abstract] [Full Text] [Related]
15. Michigan's next wave of biopharmaceutical entrepreneurship.
Kerppola R; van de Walle M; Surine S
Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575
[No Abstract] [Full Text] [Related]
16. Selling out.
Martin JF
Nat Biotechnol; 2010 Apr; 28(4):315-7. PubMed ID: 20383912
[No Abstract] [Full Text] [Related]
17. The promise of the East: India and China as R&D options.
Goodall S; Janssens B; Wagner K; Wong J; Woods W; Yeh M
Nat Biotechnol; 2006 Sep; 24(9):1061-4. PubMed ID: 17061321
[No Abstract] [Full Text] [Related]
18. Commercializing biotechnology in the UK.
Searle S; Graves B; Towler C
Nat Biotechnol; 2003 Jul; 21 Suppl():BE33-5. PubMed ID: 12874976
[No Abstract] [Full Text] [Related]
19. Giving your spinout the right spin.
McElroy D
Nat Biotechnol; 2003 Jul; 21 Suppl():BE39-41. PubMed ID: 12874978
[No Abstract] [Full Text] [Related]
20. Partnering for better microbial diagnostics.
Perkins MD; Small PM
Nat Biotechnol; 2006 Aug; 24(8):919-21. PubMed ID: 16900130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
